ADBiotech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	638.53	3,015	1,179	1,195	2,438
Short-Term Investments	630	630	4,547	120	96
Trading Asset Securities	410.72	5,769	2,901	1,465	308.11
Cash & Short-Term Investments	1,679	9,414	8,628	2,781	2,842
Cash Growth	-82.16%	9.11%	210.28%	-2.17%	-
Accounts Receivable	2,930	1,596	1,873	3,497	1,733
Other Receivables	108.46	8.07	47.67	3.28	383.27
Receivables	3,039	1,604	2,321	3,500	2,117
Inventory	2,375	2,265	2,952	2,106	1,774
Prepaid Expenses	152.11	16.83	59.27	81.21	394.93
Other Current Assets	1,144	117.63	163.87	204.67	121.52
Total Current Assets	8,390	13,417	14,123	8,672	7,249
Property, Plant & Equipment	11,061	10,312	10,319	10,287	7,423
Long-Term Investments	1,923	1,585	6,491	1,878	3,938
Goodwill	704.45	1,126	-	-	-
Other Intangible Assets	898.15	1,029	2.4	5.11	11.94
Long-Term Accounts Receivable	-	-	-	0	0
Other Long-Term Assets	98.42	623.51	83	117.09	218.03
Total Assets	23,074	28,093	31,018	20,959	18,840
Accounts Payable	1,669	250.65	386.05	1,116	485.06
Accrued Expenses	585.44	212.78	250.12	341.01	401.94
Short-Term Debt	6,735	9,142	9,543	9,147	3,140
Current Portion of Long-Term Debt	653.96	399.08	166.56	773.78	55.45
Current Portion of Leases	60.72	89.38	21.09	19.92	24.95
Other Current Liabilities	3,797	1,174	1,426	1,229	1,387
Total Current Liabilities	13,501	11,268	11,793	12,626	5,495
Long-Term Debt	3,859	3,513	3,012	3,179	3,952
Long-Term Leases	413.32	466.24	28.1	49.18	65.3
Long-Term Deferred Tax Liabilities	483.29	205.32	-	-	-
Other Long-Term Liabilities	0	0	-	-	-
Total Liabilities	18,304	15,525	14,833	15,854	9,513
Common Stock	4,570	4,570	4,570	3,847	1,267
Additional Paid-In Capital	25,557	27,257	27,257	18,293	20,582
Retained Earnings	-24,381	-16,431	-13,574	-16,270	-13,606
Comprehensive Income & Other	-909.44	-2,004	-2,068	-763.03	1,084
Total Common Equity	4,837	13,393	16,185	5,106	9,327
Minority Interest	-1,862	-2,545	-	-	-
Shareholders' Equity	4,771	12,569	16,185	5,106	9,327
Total Liabilities & Equity	23,074	28,093	31,018	20,959	18,840
Total Debt	11,722	13,610	12,771	13,168	7,238
Net Cash (Debt)	-10,043	-4,196	-4,143	-10,388	-4,396
Net Cash Per Share	-1098.75	-458.68	-410.96	-1351.57	-879.51
Filing Date Shares Outstanding	9.14	9.14	9.14	7.69	5
Total Common Shares Outstanding	9.14	9.14	9.14	7.69	5
Working Capital	-5,111	2,149	2,330	-3,954	1,754
Book Value Per Share	529.16	1465.20	1770.73	663.67	1866.18
Tangible Book Value	3,234	11,237	16,183	5,100	9,316
Tangible Book Value Per Share	353.83	1229.37	1770.47	663.00	1863.79
Land	5,321	3,868	3,868	641.06	641.06
Buildings	4,192	4,323	4,455	4,586	4,491
Machinery	967.43	1,411	1,729	2,201	318.5
Construction In Progress	-	14.4	117.47	2,784	1,864

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.